We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rosslyn Data Technologies Plc | LSE:RDT | London | Ordinary Share | GB00BMV2DB09 | ORD GBP0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -2.38% | 10.25 | 10.00 | 10.50 | 10.50 | 10.25 | 10.50 | 32,808 | 15:01:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 4.52M | 372k | 0.0211 | 4.86 | 1.81M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/4/2022 06:31 | Well, should be news very soon as I've heard that the new product and brand launch are very close! Additionally, RDT now has a PR company on board which is a first, perhaps suggesting the tide is turning at last and news ahead likely.Sounding like a broken record, but trading on less than 2xARR and then there is the cash. | hastings | |
30/3/2022 08:34 | It's a bit painful isn't it!There should be something imminent re-the new product launch, but hey ho. | hastings | |
30/3/2022 07:32 | No, I have been watching and at the moment I see nothing to encourage me into reinvesting I’m afraid. DC | daicaprice | |
30/3/2022 07:28 | The new broom has not swept well at all. | kemche | |
30/3/2022 07:19 | Just keep telling myself to be patient...........! | chrisdgb | |
01/3/2022 16:45 | Still sellers around but they don’t seem to want to mark it down any further to create a market, @3p or just over I’d be very tempted for a long term hold. DC | daicaprice | |
09/2/2022 15:46 | It’s a tricky one Chris, well undervalued and going to be a profitable long term hold but ……… DC | daicaprice | |
09/2/2022 15:30 | This screams buy but do I want to tie up more funds...?? | chrisdgb | |
04/2/2022 16:19 | Justin & I talk about Rosslyn (starts 34:40) here in today's Stock Picking video. www.youtube.com/watc | brummy_git | |
31/1/2022 09:06 | We’d had the warning but it does look positive from here with new contracts, possible disposal, cash in hand and a new hand on the tiller. DC | daicaprice | |
31/1/2022 08:52 | Albeit there's still plenty to do, I believe the tools are now in place to drive a material improvement in Rosslyn's performance over the next few years. Find out why here. www.linkedin.com/pos | brummy_git | |
31/1/2022 08:10 | Well that was a short sharp kick in the danglies. The kindest description would be "work in progress". The unkindest would be unprintable. | kemche | |
20/1/2022 11:32 | The Langdon disposal is a curve ball for me but at the right price............ | chrisdgb | |
14/1/2022 12:49 | A couple of large and interesting trades over the last 24 hours! | hastings | |
13/1/2022 10:21 | That's a very good summary Paul, thanks. | hastings | |
13/1/2022 09:59 | My latest thoughts here wrt Rosslyn's trading update today www.linkedin.com/pos | brummy_git | |
13/1/2022 09:56 | I spoke with the CEO a couple of months back but didn't add a write up at the time.However he did say then that Langdon could be sold, adding it was already run as a separate business that could be worth a decent sum to RDT. He also talked of the US as more recently providing decent contract wins such as the Pharma customer as previously mentioned and he saw plenty to go for over there and potential for decent upside.No surprise either that they are exiting low value business which perhaps in part accounts for reduced revenue.All in all he sees the product as very good, but one that was in need of revamping etc.A name change was also mentioned to better reflect what the business is and where he wants to take it.P | hastings | |
13/1/2022 09:24 | The effect on the share price of the poor trading is mitigated by, with the m/cap at low levels anyway, (a) the significant cash pile which per today's new Cenkos forecast is estimated to be £3.4m at the year end, and (b) the relatively high recurring income. Plus potentially (c) the sale proceeds from Langdon and/or Integritie. Langdon was only acquired just over two years ago, and should do well in the coming years due to Brexit, so this seems a strange time to divest. Or perhaps RDT want to take advantage of its prospects to maximise the sale proceeds given its apparent lack of synergy with the rest of the Group . | rivaldo | |
13/1/2022 08:43 | Bouncing back nicely after the early sell off. DC | daicaprice | |
13/1/2022 07:57 | The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm. The best bit, should get a mention. DC | daicaprice | |
13/1/2022 07:56 | Just looking at the significant shareholders I note Canaccord with 10.3%. Can't say I saw that one before, or perhaps I missed it! | hastings | |
13/1/2022 07:48 | Yes, work in progress still. DC | daicaprice | |
13/1/2022 07:17 | Also looks as though they plan to sell on the Langdon business reading through the blurb. | hastings | |
13/1/2022 07:12 | Unfortunately the TU contains a profit warning. RDT provides the following trading update. During the year, the Group has invested in its growth, with a number of key hires being made, whilst also remaining disciplined on costs and the Board will continue to explore ways to minimise costs. The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm. At the same time, there has been a focus on exiting non-profitable business lines, to enable the Company to focus on larger, more profitable contracts. However, and as has been reported previously, larger contracts have lengthy lead times and Covid restrictions that have been experienced across the economy have lengthened these further. Whilst the Company will continue to work hard to secure further contracts before the end of the financial year, the challenges being faced, mean that the Board is taking a more conservative view on the outcome for the year ending 30 April 2022 and now expects revenue to be no less than GBP6.0m, with ARR to be at least GBP5.1m and a corresponding impact on EBITDA. Paul Watt, CEO, commenting, "Like many businesses we have not been immune to the effects of the pandemic and this is reflected in our anticipated financial performance for the current calendar year. However, with a refreshed leadership team, a great core product and a clear strategy now in place I believe that there are significant opportunities available to the Group to drive growth and deliver shareholder value and am excited to look to the future." | masurenguy | |
12/1/2022 08:56 | A few more tucked away @4.31p. DC | daicaprice |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions